In 1994 it was shown that leukemic cells possessing the CD34+CD38- cell-surface markers were able to initiate leukemia in severe combined immunodeficiency (SCID) mice, while CD34+ or certain CD34+CD38+ expressing cells were unable to do so. This evidence concerns the gene CD34 and leukemia.